Navigation Links
Marken Announces Its New Logistics Operating System: Maestro™
Date:12/13/2011

LONDON, Dec. 13, 2011 /PRNewswire/ -- Marken announced today that it has significantly upgraded its existing operating system with centralized web-based application exclusively designed for its growing supply chain organization.  The system, known as 'Maestro' has an innovative flexible architecture which will enable extensive tracking of shipments, integrated documentation, client reporting and performance monitoring.  It is designed explicitly for ease of integration with client's systems to meet their growing requirements with temperature and time sensitive drugs to be shipped worldwide. Its interfaces and flexible structure enables each of its clients to input and track relevant data connected with a clinical trial and manage the hand-offs between shipments from site to lab and country to country.  This new operating system, when coupled with Marken's new Solo™ system for its depot operations, will allow Marken to manage the complete inbound and outbound cycle for clinical trials.

(Logo:  http://photos.prnewswire.com/prnh/20110930/NY78064LOGO )

"We are very proud to announce the new Maestro system to our clients," said Cyril Leger, Chief Operating Officer, Marken.  "We have been working on this new system for many months and have incorporated our best thinking as well as feedback from our clients.  Our customer service representatives can now work more efficiently around the clock, across all of our 24 branch locations, and track shipments more precisely than ever before."

"We at Marken are committed to continuing our journey towards perfection in supply chain management," said Wes Wheeler, CEO, Marken. "We know how important it is to be trusted with our clients' proprietary drugs, kits and samples.  Time is critical in the race for new drug treatments and we want to play our part, whatever it takes."

About Marken

Marken is the leading global clinical supply chain service provider dedicated to the pharmaceutical and life sciences industries, supporting over 6,000 investigator sites in more than 100 countries. With decades of experience in the logistics, transport and distribution of temperature sensitive life saving pharmaceuticals, clinical trial supplies and specimen collection; Marken integrates depot and logistics services into solutions that extend the reach of clinical trials to even the most remote treatment naive geographies. Our team members and network of facilities bridge the distance between patients and the essential resources of life science companies.

 


'/>"/>
SOURCE Marken
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Marken Announces Appointment of Christopher OConnell as New Chief Financial Officer
2. Marken Announces the Opening of a Directly Owned Clinical Trial Supply Depot in Singapore
3. Marken Rapidly Responds to Global Supply Chain Security Measures
4. Marken Unveils New Japan Office
5. Keryx Biopharmaceuticals Announces Phase 2 Data for KRX-0401 (Perifosine) in Hodgkins Lymphoma Presented at ASH Meeting
6. Physicians Capital Investments Announces Relocation of its Corporate Headquarters to Dallas, TX
7. Stereotaxis Announces Initial Shipments of the Epoch™ Platform to Customers
8. Jazz Pharmaceuticals Announces Stockholder Vote in Favor of Transaction With Azur Pharma Limted
9. Valeant Announces the Completion of the Privatization of Afexa Life Sciences Inc.
10. Nonin Medical Announces the European Launch of EQUANOX Advance™ Neonatal/Pediatric Sensor for Regional Oximetry at PGA Conference
11. SRP Announces Plan Doc Builder for TPAs and Brokers of Healthcare Plans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... , May 23, 2017  Leaf Healthcare, recognized ... medical devices for pressure ulcer prevention, will unveil ... Association of Critical Care Nurses, National Teaching Institute ... The Leaf Patient Monitoring System is ... the hospital environment.  The system seamlessly tracks patient ...
(Date:5/18/2017)... 17, 2017  Bayer announced today that the latest ... presented at the 53 rd Annual Meeting of ... June 2-6 in Chicago . ... prostate, colorectal, liver and thyroid cancers, as well as ... II CHRONOS-1 trial of copanlisib in patients with relapsed ...
(Date:5/11/2017)... May 11, 2017  Thornhill Research Inc. ( ... awarded an $8,049,024 USD five-year, firm-fixed-priced, indefinite-quantity/indefinite-delivery contract ... Canadian Commercial Corporation (CCC) ( Ottawa, Ontario, ... to administer general anesthesia to patients requiring emergency ... "The US Marine Corps have been a longtime ...
Breaking Medicine Technology:
(Date:5/24/2017)... (PRWEB) , ... May 24, 2017 , ... ... Maass Medical Center CEO Mary Ellen, hospital employees, and town officials to celebrate ... , The facility was developed by Rendina as part of its ongoing relationship ...
(Date:5/24/2017)... ... May 24, 2017 , ... Dr. Alan I. Benvenisty, MD ... New York City. He is known for his distinguished expertise and experience in the ... Benvenisty holds sub-specialty training in treating renovascular disease and aortic aneurysm . He ...
(Date:5/24/2017)... , ... May 24, 2017 , ... ... medical image management and interpretation, has received U.S. Food and Drug Administration (FDA) ... is a web-based, scalable and secure cloud platform for medical image management. At ...
(Date:5/24/2017)... ... May 24, 2017 , ... Dr. Manju R. Kejriwal, a leading ... orthodontics, with or without a referral. Dr. Kejriwal understands the emotional and financial toll ... braces in Cincinnati, OH. Patients no longer need to feel the esthetic effects of ...
(Date:5/24/2017)... ... May 24, 2017 , ... STATEMENT OPPOSING PRESIDENT ... opposed to Donald Trump’s budget, “A New Foundation for American Greatness—President's Budget FY ... the poor, marginalizes underserved populations, undermines productivity, and destroys the social safety net ...
Breaking Medicine News(10 mins):